CareDx's AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage for Lung Transplant Rejection Monitoring
AlloSure Lung Represents First dd-cfDNA Approved by Medicare for Lung Transplant Patients
Stay updated with breaking news from Greg Seeto. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AlloSure Lung Represents First dd-cfDNA Approved by Medicare for Lung Transplant Patients
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum ind...
2023 marks a milestone for the Globeride and Daiwa family with Daiwa Australia celebrating its 50th year in the Australian fishing tackle industry. Daiwa has a rich global history with its genesis deeply rooted in Japanese culture.
Record Number of 65 Abstracts Showcasing CareDx Innovation Including Data Showing Clinical Utility of AlloSure Kidney to Guide Immunosuppression Management Experts Review Advancements in... | June 1, 2023
CareDx, Inc. – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients... | May 10, 2023